Maureen E. Garnett

612 total citations
16 papers, 498 citations indexed

About

Maureen E. Garnett is a scholar working on Molecular Biology, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, Maureen E. Garnett has authored 16 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Physiology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Maureen E. Garnett's work include Cardiac Ischemia and Reperfusion (4 papers), Anesthesia and Neurotoxicity Research (3 papers) and Glutathione Transferases and Polymorphisms (2 papers). Maureen E. Garnett is often cited by papers focused on Cardiac Ischemia and Reperfusion (4 papers), Anesthesia and Neurotoxicity Research (3 papers) and Glutathione Transferases and Polymorphisms (2 papers). Maureen E. Garnett collaborates with scholars based in Canada. Maureen E. Garnett's co-authors include David V. Godin, Saleh A. Wohaieb, D. V. Godin, David M. Ansley, A. Karim Qayumi, Robert C. Thompson, Cathleen R. Nichols, W. Anton Visser, Kimberly M. Cheng and Gordon Hoag and has published in prestigious journals such as British Journal of Pharmacology, Biochimica et Biophysica Acta (BBA) - Biomembranes and The Journal of Membrane Biology.

In The Last Decade

Maureen E. Garnett

16 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maureen E. Garnett Canada 10 118 107 94 71 66 16 498
J. Kalra Canada 17 115 1.0× 162 1.5× 211 2.2× 40 0.6× 12 0.2× 30 740
Toru Obata Japan 19 41 0.3× 127 1.2× 291 3.1× 24 0.3× 22 0.3× 62 984
Joseph L. Haining United States 13 138 1.2× 91 0.9× 159 1.7× 35 0.5× 13 0.2× 27 636
Marie‐Christine Delmas‐Beauvieux France 13 46 0.4× 85 0.8× 91 1.0× 41 0.6× 17 0.3× 18 467
Jeffrey K. Beckman United States 14 71 0.6× 62 0.6× 255 2.7× 53 0.7× 13 0.2× 20 716
K Nishiki United States 15 77 0.7× 214 2.0× 382 4.1× 57 0.8× 10 0.2× 19 954
Antonella Boraso Italy 11 119 1.0× 97 0.9× 217 2.3× 24 0.3× 8 0.1× 24 539
Karl B. Sluis New Zealand 6 41 0.3× 130 1.2× 253 2.7× 80 1.1× 25 0.4× 8 915
Dipak K. Das United States 9 149 1.3× 81 0.8× 131 1.4× 11 0.2× 35 0.5× 10 404
M.M. Arrebola Spain 14 21 0.2× 56 0.5× 65 0.7× 35 0.5× 20 0.3× 29 454

Countries citing papers authored by Maureen E. Garnett

Since Specialization
Citations

This map shows the geographic impact of Maureen E. Garnett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen E. Garnett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen E. Garnett more than expected).

Fields of papers citing papers by Maureen E. Garnett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen E. Garnett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen E. Garnett. The network helps show where Maureen E. Garnett may publish in the future.

Co-authorship network of co-authors of Maureen E. Garnett

This figure shows the co-authorship network connecting the top 25 collaborators of Maureen E. Garnett. A scholar is included among the top collaborators of Maureen E. Garnett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maureen E. Garnett. Maureen E. Garnett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Godin, David V., et al.. (2003). Alterations in aortic antioxidant components in an experimental model of atherosclerosis: A time-course study. Molecular and Cellular Biochemistry. 252(1-2). 193–203. 4 indexed citations
2.
Godin, David V., et al.. (2002). Red cell and plasma antioxidant components and atherosclerosis in Japanese quail: a time-course study.. PubMed. 110(1-2). 27–51. 2 indexed citations
3.
Ansley, David M., et al.. (1999). High dose propofol enhances red cell antioxidant capacity during CPB in humans. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 46(7). 641–648. 38 indexed citations
4.
Ansley, David M., et al.. (1998). Propofol enhances red cell antioxidant capacity in swine and humans. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 45(3). 233–239. 53 indexed citations
5.
Nichols, Cathleen R., et al.. (1998). Dietary cholesterol-induced xanthomatosis in atherosclerosis-susceptible Japanese quail (Cotunix japonica). Journal of Comparative Pathology. 119(4). 419–427. 18 indexed citations
6.
Godin, D. V. & Maureen E. Garnett. (1994). Effects of various anesthetic regimens on tissue antioxidant enzyme activities.. PubMed. 83(1). 93–101. 18 indexed citations
7.
Godin, David V. & Maureen E. Garnett. (1992). Species-related variations in tissue antioxidant status—II. Differences in susceptibility to oxidative challenge. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 103(3). 743–748. 34 indexed citations
8.
Godin, David V. & Maureen E. Garnett. (1992). Species-related variations in tissue antioxidant status—I. Differences in antioxidant enzyme profiles. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 103(3). 737–742. 50 indexed citations
9.
Godin, D. V. & Maureen E. Garnett. (1989). Altered antioxidant status in the ischemic/reperfused rabbit myocardium: effects of allopurinol.. PubMed. 5(7). 365–71. 42 indexed citations
10.
Godin, David V., et al.. (1988). Antioxidant enzyme alterations in experimental and clinical diabetes. Molecular and Cellular Biochemistry. 84(2). 223–231. 165 indexed citations
11.
Godin, D. V., et al.. (1988). Erythrocyte abnormalities in a hypoalphalipoproteinemia syndrome resembling fish eye disease. European Journal Of Haematology. 41(2). 176–181. 2 indexed citations
12.
Garnett, Maureen E., et al.. (1984). In vivo and in vitro studies of bacterial endotoxin‐membrane interactions and the effects of membrane‐active agents. British Journal of Pharmacology. 83(1). 15–21. 1 indexed citations
13.
Godin, David V., et al.. (1982). Studies on the interaction of Escherichia coli endotoxin with erythrocyte membranes. Canadian Journal of Physiology and Pharmacology. 60(7). 977–985. 10 indexed citations
14.
Godin, David V., et al.. (1978). Acetylcholinesterase: A probe for the study of antiarrhythmic drug-membrane interactions. Biochimica et Biophysica Acta (BBA) - Biomembranes. 512(2). 388–396. 6 indexed citations
15.
Godin, David V. & Maureen E. Garnett. (1976). Perturbational effects of inorganic cations on human erythrocyte membranes. The Journal of Membrane Biology. 28(1). 143–168. 6 indexed citations
16.
Garnett, Maureen E., et al.. (1975). Magnetic and Spectral Studies on Cobalt(II) and Copper(II) Salts of Methylsulfuric, Trifluoromethylsulfuric, and Paratolylsulfuric Acids. Canadian Journal of Chemistry. 53(24). 3812–3819. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026